Benoît Adelus has over 30 years of experience within the Animal Health / Medtech / IVD (In Vitro Diagnostics) sectors in senior leadership roles across different geographies. Most recently, he was the Chairman and CEO of Sebia, and before that he led the 2004 stock listing of bioMérieux while CEO there. Previously, Benoit served as COO at Merial, the animal pharma and vaccine leader.
He successfully managed three LBOs while CEO at Sebia, and oversaw two more in a Chairman role at St Hubert and Arkopharma.
He has a long-standing relationship with the ArchiMed team, through non-executive Directorships at Carso and Medistream / Citieffe.
Benoît graduated with a doctorate in Veterinary Medicine from the Ecole Nationale Vétérinaire de Nantes and holds an MBA from HEC.